Abstract
The effects of gonadal hormones on serum lipids have been of great interest to the physician because of the considerably greater vulnerability of men to coronary heart disease in comparison with women, whose lesser vulnerability to coronary artery disease has been, until recently, popularly attributed to a presumed cholesterol-lowering effect of ovarian estrogen.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Furman, R.H.: Are gonadal hormones (estrogens and androgens) of significance in the development of ischemic heart disease? Ann. New York Acad. Sci. 149:822–833 (1968).
Komerup, V.: Concentrations of cholesterol, total fat and phospholipid in serxim of normal men. Arch. Int. Med. Exp. 85:398–415 (1950).
Peters, J.P. and Van Slyke, D.D.: Quantitative Clinical Chemistry. Interpretations, Vol. 1 (Williams and Wilkins Co., Baltimore, 1946).
Block, W.J., Barker, N.W. and Mann, F.D.: Effect of small doses of heparin in increasing the transluscence of plasma during alimentary lipemia. Studies in normal persons and patients having atherosclerosis. Circulation 4:674–678 (1951).
Moore, F.E. and Gordon, T.: Serum cholesterol levels of adults. United States 1960–1962, U.S. Department of Health, Education and Welfare, National Center for Health Statistics, Series 11, Number 22, United States Government Printing Office, Washington, D.C. (1967).
Oliver, M.F. and Boyd, G.S.: Changes in the plasma lipids during the menstrual cycle. Clin. Sci. 12:217–222 (1953).
Adlercreutz, H. and Tallqvist, G.: Variations in the serum total cholesterol and hematocrit values in normal women during the menstrual cycle. Scand. J. Clin. Lab. Invest. 11:1–9 (1959).
Peters, J.P., Heineman, M. and Man, E.B.: The lipids of serum in pregnancy. J. Clin. Invest 30:388–394 (1951).
Mann, G.V. and Shaffer, R.D.: Cholesteremia in pregnant Masai women. J. Am. Med. Assoc. 197:1071–1073 (1966).
Adlercreutz, H., Kerstell, J. and Svanborg, A.: Simultaneous estimation of plasma cholesterol, total and individual phospholipids, triglycerides, free fatty acids and Cortisol, and urinary estrogens, total 17-ketosteroids, individual 11-deoxy- 17-ketosteroids and pregnanediol during the menstrual cycle and in early pregnancy. Ann. Med. Exp. Fenn. 45:285–292 (1967).
Eilert, M.L.: The effects of estrogens upon the partition of the serum lipids in female patients. Amer. Heart J. 38:472 (1949).
Ellert, M.L.: The effect of estrogens upon the partition of the serum lipids in female patients. Metabolism 2: 137–145 (1953).
Oliver, M.F. and Boyd, G.S.: The effect of estrogens on the plasmia lipids in coronary artery disease. Amer. Heart J. 47: 348–359 (1954).
Oliver, M.F. and Boyd, G.S.: The influence of the sex hormones on the circulatory lipids and lipoproteins in coronary sclerosis. Circulation 13:82–91 (1956).
Barr, D.P., Russ, E.M. and Eder, H.A.: Influence of estrogens on lipoproteins in atherosclerosis. Trans. Assoc. Amer. Physicians 65: 102–113 (1952).
Barr, D.P.: Some chemical factors in the pathogenesis atherosclerosis. Circulation 8: 641–654 (1953).
Barr, D.P., Russ, E.M. and Eder, H.A.: Section VII of Blood cells and plasma proteins; in Tullis’ Protein-lipid relationships in plasma, Ch. 4 (Academic Press, New York 1953).
Russ, E.M., Eder, H.A. and Barr, D.P.: Influence of gonadal hormones on protein-lipid relationships in human plasma. Amer. J. Med. 19:4–24 (1955).
Steiner, A., Payson, H. and Kendall, F.E.: Effect of estrogenic hormone on serum lipids in patients with coronary atherosclerosis. Circulation 11:784–788 (1955).
Marett, W.C. and Vivas, J.R.: The effect of oral estrogens on serum cholesterol and total lipids. U.S. Armed Forces Med. J. 4: 1439–1448 (1953).
Gitman, L. and Greenblatt, I.J.: Effect of intravenously administered estrogen in cardiovascular disease. Angiology 4:502–509 (1953).
Gertler, M.M., Hudson, P.B. and Jost, H.: Effects of castration and diethylstilbestrol on the serum lipid pattern in man. Geriatrics 8:500–503 (1953).
Robinson, R.W., Higano, N., Cohen, W.D., Sniffen, R.C. and Sherer, J.W., Jr.: Effects of estrogen therapy on hormonal functions and serum lipids in men with coronary atherosclerosis. Circulation 14:365–372 (1956).
Furman, R.H., Alaupovic, P. and Howard, R.P.: Effects of androgens and estrogens on seriam lipids and the composition and concentration of serum lipoproteins in normolipemic and hyper- lipidemic states. Prog. Biochem. Pharmacol. 2:215–249 (Basel/ New York 1967).
Furman, R.H., Howard, R.P., Norcia, L.N. and Keaty, E.G.: The influence of androgens, estrogens and related steroids on serum lipids and lipoproteins. Observations in hypogonadal and normal human subjects. Amer. J. Med. 24: 80–97 (1958).
Russ, E.M., Eder, H.A. and Barr, D.P.: Protein-lipid relationships in humn plasma. I. In normal individuals. Amer. J. Med. 11: 468–479 (1951).
Lewis, L.A., Green, A.A. and Page, I.H.: Ultracentri- fuge lipoprotein patterns of serum of normal, hypertensive and hypothyroid animals. Amer. J. Physiol. 171:391–400 (1952).
Lewis, L.A., Green, A.A. and Page, I.H.: The alpha and beta lipoprotein pattern of normal and pathological human sera. Fed. Proc. 10:84 (1951).
Lewis, L.A. and Page, I.H.: Electrophoretic and ultracentrifugal analysis of serum lipoproteins of normal, nephrotic and hypertensive persons. Circulation 7: 707–717 (1953).
Gofman, J.W., Jones, H.B., Lindgren, F.T., Lyon, T.P., Elliott, H.A. and Strisower, B.: Blood lipids and human atherosclerosis. Circulation 2: 161–178 (1950).
Havel, R.J., Eder, H.A. and Bragdon, J.H.: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1345–1353 (1955).
Nikkila, E.: Studies on the lipid-protein relationships in normal and pathological sera and the effect of heparin on serum lipoproteins. Scand. J. Clin. Lab. Invest. (Suppl. 8) 5:1–101 (1953).
Antonini, F.M., Piva, G., Salvini, L. and Sordi, A.: Lipoproteine ed eparina nel guardo umorale della chemiopatogenesi dell’arterosclerosi. Gior. Gerontol. (Suppl. 1), 1–96 (1953).
Furman, R.H., Howard, R.P. and Imagawa, R.: Serum lipid and lipoprotein concentrations in castrate and noncastrate institutionalized male subjects. Circulation 14:490–491 (1956).
Barclay, K., Barclay, R.K., Skipski, V.P., Terebus-Kekish, O., Mueller, E.S. and Elkins, W.L. :Fluctuations in human serum lipoproteins during the normal menstrual cycle. Biochem. J. 96:205–209 (1965).
Barr, D.P.: Influence of sex and sex hormones upon the development of atherosclerosis and upon the lipoproteins of plasma. J. Chron. Dis. 1:63–85 (1955).
Glass, S.J., Engelberg, H., Marcus, R., Jones, H.B. and Gofman, J.: Lack of effect of administered estrogens in the serum lipids and lipoproteins of male and female patients. Metabolism 2: 133–136 (1953).
Engelberg, H. and Glass, S.J.: Influence of physiologic doses of sex steroid hormones on serum lipids and lipoproteins in humans. Metabolism 4:298–301 (1955).
Oliver, M.F. and Boyd, G.S.: Endocrine aspects of coronary sclerosis. Lancet 2: 1273 (1956).
Howard, R.P. and Furman, R.H.: Metabolic and serum lipid effects of methylandrostane and methylandrostene pyrazoles. J. Clin. Endo. Metab. 22:43–51 (1962).
Furman, R.H., Howard, R.P., Lakshmi, K. and Norcia, L.N.: The serum lipids and lipoproteins in normal and hyperlipidemic subjects as determined by preparative ultracentrifugation. Effects of dietary and therapeutic measures. Changes induced by in vitro exposure of serum to sonic forces. Amer. J. Clin. Nutr. 9: 73–102 (1961).
Furman, R.H., Norcia, L.N., Robinson, C.W., Jr. and Gonzalez, I.E.: Influence of testosterone, methyltestosterone and dl-ethionine on canine liver lipids, serum lipids and lipoproteins. Amer. J. Physiology 191:561–572 (1957).
Furman, R.H., Robinson, C.W., Jr., Bradford, R.H., Alaupovic, P. and Norcia, L.N.: Methyltestosterone effect on serum cholesterol radioactivity in dogs given C14-acetate. Proc. Soc. Exper. Biol, and Med. 113: 789–794 (1963).
Mosbach, E.H., Abell, L.L. and Kendall, F.E.: In Drugs Affecting Lipid Metabolism. Elsevier Publishing Company, The Netherlands, pp. 119–131 (1961).
Abell, L.L. and Mosbach, E.H.: Hypocholesterolemic effect of methyltestosterone in rats. J. Lipid Res.3: 88–91 (1962).
Raiford, R.L. and Wong, H.Y.C.: In vivo incorporation of acetate-l-C14 into cholesterol and fatty acids following testosterone propionate administration. Circulation Res. 11:752- 757 (1962).
Abell, L.L., Mosbach, E.H. and Kendall, F.E.: Influence of diet on the hypocholesterolemic action of methyltestosterone in dogs. J. Nutrition 87: 285–292 (1965).
Alaupovic, P., Howard, R.P. and Furman, R.H.: Effect of estrogens and androgens on the alpha and beta lipoprotein composition in human subjects. Circulation 28: 647 (1963).
Furman, R.H., Sanbar, S.S., Alaupovic, P., Bradford, R.H and Howard, R.P.: Studies of the metabolism of radioiodinated human serum alpha lipoprotein in normal and hyperlipidemic subjects. J. Lab. Clin. Med. 63: 193–204 (1964).
Levy, R.I., Lees, R.S. and Fredrickson, D.S.: A functional role for plasma alphai lipoproteins. J. Clin. Invest. 44:1068 (1965).
Furman, R.H., Howard, R.P. and Norcia, L.N.: In Hormones and Atherosclerosis, G. Pincus, Editor, Academic Press, New York, Ch. 25, pp. 349–370 (1958).
Furman, R.H., Howard, R.P. and Norcia, L.N.: Modification of the responses of serum lipids, lipoproteins, and urinary creatine excretion to androgen and estrogen administration following isocaloric substitution of carbohydrate for dietary protein. J. Lab. Clin. Med. 52:813–814 (1958).
Crider, Q.E., Bradford, R.H. and Furman, R.H.: Effect of methyltestosterone on the protein moiety of canine serum alpha- lipoproteins. Circulation 32 (II):8 (1965).
Aurell, M., Cramer, K. and Rybo, G.: Serum lipids and lipoproteins during long term administration of an oral contraceptive. Lancet 1:291–293 (1966).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1969 Plenum Press, New York
About this chapter
Cite this chapter
Furman, R.H. (1969). Gonadal Steroid Effects on Serum Lipids. In: Salhanick, H.A., Kipnis, D.M., Wiele, R.L.V. (eds) Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1782-1_19
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1782-1_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1784-5
Online ISBN: 978-1-4684-1782-1
eBook Packages: Springer Book Archive